Researchers at DTU have patented a new invention that uses naturally produced substances from bifidobacteria in the gut to help lower the risk of allergies and asthma. Allergies and asthma are ...

Alma Figueroa began to worry when she learned that her gas provider wanted to test a controversial solution to curb global ...

Allergies and asthma affect an increasing number of children worldwide, but now an international research group led by DTU ...

A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won European regulatory approval for two inflammatory disease indications. The European Medicines Agency's ...

Home remedies can include honey to soothe throat irritation and steam to hydrate airways. Chronic conditions like asthma or GERD may require medication to ease a cough. See a provider if your cough ...

A dry cough occurs as a natural reflex when inflammation or irritation affects your airway. It is also called an unproductive cough since it does not produce phlegm or mucus. A dry cough can be ...

Please provide your email address to receive an email when new articles are posted on . The annualized exacerbation rate was 3.18 per patient-year before tezepelumab and 1.97 per patient-year after ...

Asthma is one of the most common chronic respiratory diseases among children, affecting nearly 475 million globally. For decades, exercise was discouraged due to the risk of triggering wheezing and ...

Please provide your email address to receive an email when new articles are posted on . Corticosteroids cause weight gain, worsening asthma and requiring more medication. GLP-1 receptor agonists ...